As Sussan Ley exits politics, her tenure as health minister is best remembered for driving some of the most structurally significant reforms to the Pharmaceutical Benefits Scheme in decades, reshaping pricing, governance, industry engagement, and patient access despite at times intense opposition.
Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Queensland cardiac experts back a new plan to stop the second heart attack
September 18, 2026 - - Latest News -
We have one of Australia's answers to 'MFN' and people will die as a result
September 18, 2026 - - Latest News -
Is the fairest part of our medicines access system delivered overseas?
September 18, 2026 - - Latest News -
Mayne Pharma bets on an untapped corner of the menopause market
September 17, 2026 - - Latest News -
Genomic testing to reach more patients with hard to treat cancers
September 17, 2026 - - Latest News -
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
'Your success makes you a target and take it as a compliment'
September 16, 2026 - - Latest News
